Skip to main content
. 2017 Jun 13;114(26):E5077–E5084. doi: 10.1073/pnas.1705757114

Fig. 6.

Fig. 6.

The effect of fractalkine release on axonal growth. (A) Immunohistochemical staining of axons (red) and DAPI (blue) at the distal end of nerve stump. (B) The number of regenerated axons at the distal end of the fractalkine- vs. the IL-4–treated scaffold in comparison with the autograft 4 wk after injury. *P < 0.05; ##P < 0.01; ####P < 0.0001 (one-way ANOVA) (n = 5). Fractalkine-treated scaffold dramatically increases the number of regenerated axons relative to IL-4, reaching very close to the number of regenerated axons in autograft.